16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
W9B28
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
12J36

Xiamen Amoytop Biotech Co., Ltd.

About Xiamen Amoytop Biotech Co., Ltd.

AMOYTOP BIOTECH, the leading manufacturer of recombinant bio-pharmaceutical products in China with cGMP, produces Molgramostim, Filgrastim, Oprelvekin, and Peginterferon alfa 2b, marketing in China and exporting to many countries, and provides bio-reagents for Lab and R&D, such as Interleukin-4, TNF-alfa, IFN-gamma, IL-15, SCF, etc. AMOYTOP is also developing Y-shaped branch PEG Drug Delivery Technology in: Pegfilgrastim, Pegsomatropin and Peg-EPO. AMOYTOP, the first and largest company to launch domestic Molgramostim in China, is Molgramostim Reference Standard supplier to National Institutes for Food and Drug Control (NIFDC), China. AMOYTOP also provides service as Contract manufacturer an...

Meet us at

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Consumer Goods
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Contact info

Products from Xiamen Amoytop Biotech Co., Ltd. (29)